These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 34495494)
1. Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta-Analysis. Gartlehner G; Crotty K; Kennedy S; Edlund MJ; Ali R; Siddiqui M; Fortman R; Wines R; Persad E; Viswanathan M CNS Drugs; 2021 Oct; 35(10):1053-1067. PubMed ID: 34495494 [TBL] [Abstract][Full Text] [Related]
2. Antipsychotics, antidepressants, anticonvulsants, and placebo on the symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials. Vita A; De Peri L; Sacchetti E J Clin Psychopharmacol; 2011 Oct; 31(5):613-24. PubMed ID: 21869691 [TBL] [Abstract][Full Text] [Related]
8. Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review. Melton H; Meader N; Dale H; Wright K; Jones-Diette J; Temple M; Shah I; Lovell K; McMillan D; Churchill R; Barbui C; Gilbody S; Coventry P Health Technol Assess; 2020 Sep; 24(43):1-312. PubMed ID: 32924926 [TBL] [Abstract][Full Text] [Related]
9. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms. Mercer D; Douglass AB; Links PS J Pers Disord; 2009 Apr; 23(2):156-74. PubMed ID: 19379093 [TBL] [Abstract][Full Text] [Related]
10. Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics? Abraham PF; Calabrese JR J Affect Disord; 2008 Nov; 111(1):21-30. PubMed ID: 18304647 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological interventions for people with borderline personality disorder. Binks CA; Fenton M; McCarthy L; Lee T; Adams CE; Duggan C Cochrane Database Syst Rev; 2006 Jan; (1):CD005653. PubMed ID: 16437535 [TBL] [Abstract][Full Text] [Related]
12. A Focused Systematic Review of Pharmacological Treatment for Borderline Personality Disorder. Hancock-Johnson E; Griffiths C; Picchioni M CNS Drugs; 2017 May; 31(5):345-356. PubMed ID: 28353141 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and Tolerability of Lamotrigine in Borderline Personality Disorder: A Systematic Review and Meta-Analysis. Pahwa M; Nuñez NA; Joseph B; Seshadri A; Gerberi DJ; Frye MA; Singh B Psychopharmacol Bull; 2020 Sep; 50(4):118-136. PubMed ID: 33012875 [TBL] [Abstract][Full Text] [Related]
15. Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder. Pinto OC; Akiskal HS J Affect Disord; 1998 Dec; 51(3):333-43. PubMed ID: 10333987 [TBL] [Abstract][Full Text] [Related]
16. Association of pharmacological treatments and real-world outcomes in borderline personality disorder. Lieslehto J; Tiihonen J; Lähteenvuo M; Mittendorfer-Rutz E; Tanskanen A; Taipale H Acta Psychiatr Scand; 2023 Jun; 147(6):603-613. PubMed ID: 37094828 [TBL] [Abstract][Full Text] [Related]
18. Current Clinical Psychopharmacology in Borderline Personality Disorder. Del Casale A; Bonanni L; Bargagna P; Novelli F; Fiaschè F; Paolini M; Forcina F; Anibaldi G; Cortese FN; Iannuccelli A; Adriani B; Brugnoli R; Girardi P; Paris J; Pompili M Curr Neuropharmacol; 2021; 19(10):1760-1779. PubMed ID: 34151763 [TBL] [Abstract][Full Text] [Related]
19. A systematic review of the role of clozapine for severe borderline personality disorder. Han J; Allison S; Looi JCL; Chan SKW; Bastiampillai T Psychopharmacology (Berl); 2023 Oct; 240(10):2015-2031. PubMed ID: 37572113 [TBL] [Abstract][Full Text] [Related]